Otrivin Menthol (Xylometazoline Hydrochloride)

Otrivin Menthol (xylometazoline) acts on nasal blood vessels to reduce swelling and improve airflow.

• Common cold: temporary relief of nasal congestion.
• Acute sinusitis: reduction of nasal passage swelling.
• Allergic rhinitis: alleviation of congestion caused by allergens.
• Upper respiratory tract infections: improves breathing comfort.

• Xylometazoline is a selective alpha‑adrenergic agonist that stimulates alpha‑1 and alpha‑2 receptors in the nasal mucosal vasculature. Activation causes vasoconstriction, which decreases blood flow to the nasal mucosa, reduces edema, and opens the nasal airway for easier breathing.

Side effects are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects

• Burning sensation: mild burning in the nostrils after application.
• Nasal dryness: dryness of the nasal lining.
• Sneezing: transient sneezing episodes.
• Headache: mild headache following use.
• Epistaxis: occasional mild nosebleeds.
• Taste disturbance: altered taste perception.

Serious or Rare Side Effects

• Severe nasal irritation: intense burning or swelling.
• Persistent epistaxis: prolonged or heavy nosebleeds.
• Hypertensive crisis: rapid rise in blood pressure in susceptible patients.
• Allergic reaction: rash, itching, swelling, or difficulty breathing.

When using Otrivin Menthol, consider the following safety measures:

• Do not exceed recommended duration: avoid ​         ​  ​  ​  ​  ​  ​  ​  ​  ​  ​   ​  ​  ​ ​  ​  ​  ​  ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​  ​ ​ ​​ ​​ ​ ​ ​ ​ ​ ​ ​ ​​ ​ ​ ​​ ​ ​ ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​ ​ ​ ​ ​ ​​​
• Avoid use in children under 2 years: safety not established.
• Monitor blood pressure: patients with hypertension should use with caution.
• Discontinue if severe irritation occurs: stop use and seek medical advice.
• Do not combine with other nasal decongestants: risk of additive vasoconstriction.
• Store at room temperature: keep in original packaging  ");

•   
• ---
•    """  "" " " """  " "" ""  "" ""  " "   "" "" " " " "